BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 14596638)

  • 1. Pharmacogenomics in the treatment of epilepsy.
    Clancy CE; Kass RS
    Pharmacogenomics; 2003 Nov; 4(6):747-51. PubMed ID: 14596638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Epilepsy pharmacogenetics : science or fiction?].
    Depondt C
    Med Sci (Paris); 2013 Feb; 29(2):189-93. PubMed ID: 23452606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential of pharmacogenetics in the treatment of epilepsy.
    Depondt C
    Eur J Paediatr Neurol; 2006 Mar; 10(2):57-65. PubMed ID: 16531088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic association studies in epilepsy pharmacogenomics: lessons learnt and potential applications.
    Depondt C; Shorvon SD
    Pharmacogenomics; 2006 Jul; 7(5):731-45. PubMed ID: 16886898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenomics and epilepsy: the road ahead.
    Cavalleri GL; McCormack M; Alhusaini S; Chaila E; Delanty N
    Pharmacogenomics; 2011 Oct; 12(10):1429-47. PubMed ID: 22008048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetics and the treatment of epilepsy: what do we know?
    Božina N; Sporiš IŠ; Božina T; Klarica-Domjanović I; Tvrdeić A; Sporiš D
    Pharmacogenomics; 2019 Oct; 20(15):1093-1101. PubMed ID: 31588875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacogenetics, pharmacogenomics and individualised antiepileptic therapy].
    Herranz JL
    Rev Neurol; 2006 Oct; 43 Suppl 1():S43-9. PubMed ID: 17061195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetics and antiepileptic drugs.
    Spear BB
    Epilepsia; 2001; 42 Suppl 5():31-4. PubMed ID: 11887965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interface of preclinical evaluation with clinical testing of antiepileptic drugs: role of pharmacogenomics and pharmacogenetics.
    Holmes GL
    Epilepsy Res; 2002 Jun; 50(1-2):41-54. PubMed ID: 12151116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacogenomics of epilepsy.
    Franco V; Perucca E
    Expert Rev Neurother; 2015 Oct; 15(10):1161-70. PubMed ID: 26327193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on pharmacogenetics in epilepsy: a brief review.
    Szoeke CE; Newton M; Wood JM; Goldstein D; Berkovic SF; OBrien TJ; Sheffield LJ
    Lancet Neurol; 2006 Feb; 5(2):189-96. PubMed ID: 16426995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epilepsy pharmacogenetics.
    Kasperaviciūte D; Sisodiya SM
    Pharmacogenomics; 2009 May; 10(5):817-36. PubMed ID: 19450130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of association between the C3435T polymorphism in the human multidrug resistance (MDR1) gene and response to antiepileptic drug treatment.
    Sills GJ; Mohanraj R; Butler E; McCrindle S; Collier L; Wilson EA; Brodie MJ
    Epilepsia; 2005 May; 46(5):643-7. PubMed ID: 15857428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacotherapy of epilepsy: new armamentarium, new issues.
    Vajda FJ
    J Clin Neurosci; 2007 Sep; 14(9):813-23. PubMed ID: 17618119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between ABCB1 polymorphism and response to sodium valproate treatment in Malaysian epilepsy patients.
    Haerian BS; Lim KS; Tan HJ; Mohamed EH; Tan CT; Raymond AA; Wong CP; Wong SW; Omar H; Roslan H; Mohamed Z
    Epileptic Disord; 2011 Mar; 13(1):65-75. PubMed ID: 21388909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implications of pharmacogenetics for the therapeutic use of antiepileptic drugs.
    Piana C; Antunes Nde J; Della Pasqua O
    Expert Opin Drug Metab Toxicol; 2014 Mar; 10(3):341-58. PubMed ID: 24460510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic, pharmacodynamic, and pharmacogenetic targeted therapy of antiepileptic drugs.
    Anderson GD
    Ther Drug Monit; 2008 Apr; 30(2):173-80. PubMed ID: 18367977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic drug monitoring and clinical outcomes in epileptic Egyptian patients: a gene polymorphism perspective study.
    Ebid AH; Ahmed MM; Mohammed SA
    Ther Drug Monit; 2007 Jun; 29(3):305-12. PubMed ID: 17529887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The intrinsic severity hypothesis of pharmacoresistance to antiepileptic drugs.
    Rogawski MA
    Epilepsia; 2013 May; 54 Suppl 2():33-40. PubMed ID: 23646969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of genetics and ethnicity in epilepsy management.
    Scheffer IE
    Acta Neurol Scand Suppl; 2005; 181():47-51. PubMed ID: 16238709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.